Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,317-8,328 of 10,592
Behavioral study icon
CompletedNCT01736085

Providing Free Nicotine Patches to Quitline Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Addiction
Behavioral study icon
CompletedNCT04342494

Providing Mental Health Precision Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Addiction, Depression, ...BehavioralOver 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
Addiction, Depression, ...
Drug study icon
CompletedNCT04521920

Providing Suboxone and PrEP Using Telemedicine

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Duke University
Condition
Addiction
Drug study icon
TerminatedNCT04353921

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

This study exists to understand how questionnaires and follow-up reports holds up over time after the earliest research stage. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

In United States
DepressionOtherFrom 21 Years to 65 Years
Countries
United States
Sponsor
Usona Institute
Condition
Depression
Drug study icon
Active Not RecruitingNCT06308653

Psilocybin for Major Depressive Disorder (MDD)

This study is comparing Psilocybin 25 mg with placebo for people with major depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.

In United States
DepressionDrugOver 18 Years
Countries
United States
Sponsor
Usona Institute
Condition
Depression
Drug study icon
Active Not RecruitingNCT05554094

Psilocybin for Veterans With PTSD

This study is looking at whether a digital support tool can help people with Ptsd, Stress Disorders, Traumatic, PTSD, or Trauma and Stressor Related Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
PTSDDrugFrom 21 Years to 64 Years
Countries
United States
Sponsor
Ohio State University
Condition
PTSD
Drug study icon
CompletedNCT03300947

Psilocybin for Treatment of OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Arizona
Condition
OCD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.